PERMANENT TSB GROUP HOLDINGS PLC (PTSB) — Research Note

Executive summary

PTSB is an Irish retail and SME bank focused on mortgages (c.19-20% new-flow market share), customer deposits (€25.6bn) and a growing business banking franchise, operating in a consolidating Irish market. Over the period covered, the bank completed a transformational acquisition of Ulster Bank Ireland's mortgage, SME and asset-finance books (c.€6.75bn), returned to sustainable profitability (H1 2026 underlying PBT €68m, +34% YoY), implemented IRB mortgage models and strengthened CET1 to 17.7%. The single most important point for valuation today is that PTSB is in a recommended all-cash takeover by BAWAG at €2.97/share, shareholders approved with 91% support on 30 July 2026 2026-07-30 announcement, High Court sanction and remaining regulatory approvals outstanding, expected completion Q4 2026 or Q1 2027 — so this is a merger-arb situation, not a fundamental compounding story.

Fair value estimate

Methodology: deal-driven fair value anchored at BAWAG's recommended cash offer of 297 euro cents, with a modest downside case for break risk.

• Fair value range: 285 – 300 euro cents per share (central: 297c offer price)
• Implied market cap range: €1,553m – €1,635m (central €1,619m at 545m shares)
• Latest disclosed market cap €1,635.0m; current price €3.00 (300c).
• Absolute upside/downside: approximately –1% to the offer price; essentially fully priced.

Downside-case (deal break): without a bid, fundamental value on 2027E ROTE of c.9% and tangible equity would likely imply €2.00–€2.40/share based on peer multiples for Irish/UK mid-tier banks on sub-10% ROTE (c.0.6–0.8x TBV). The market is pricing a very high probability of closing (approvals from PTSB shareholders, Minister for Finance holding 57.5% supportive, Moody's indicating potential one-notch upgrade on close).

Sector context

• Confirmed sector: Financials / Banks (ICB), Irish-incorporated retail/SME bank.
• Quality/growth profile is in line with mid-tier Irish/UK retail bank peers: moderate ROTE (c.5% H1 2026, targeting c.11% by 2028 before deal), high CET1 (17.7%), high-quality mortgage-heavy book (NPLs 1.4%), modest growth.
• Listed peers: AIB Group (AIB.I), Bank of Ireland (BIRG.I), BAWAG Group (BG.VI) (the acquirer).

Investment thesis (3 bullets)

1. Deal certainty is very high and 1% downside is effectively a short-duration cash equivalent return. Shareholders have approved with 91% 2026-07-30 scheme meeting, the Irish Minister for Finance (57.5% shareholder) is supportive 2026-04-14 BAWAG offer announcement, and the only outstanding items are High Court sanction and one remaining regulatory approval, expected Q4 2026 or Q1 2027.
2. Underlying operating momentum is strong, supporting valuation if there were any break. H1 2026 underlying PBT +34% YoY, revenue +7%, cost/income ratio down 5ppts to 71%, and new IRB mortgage models released c.€0.9bn of RWAs lifting CET1 to 17.7% 2026-07-29 half-year.
3. High-quality balance sheet protects downside. NPL ratio 1.4%, cost of risk only 5bps H1 2026, LCR 250%, MREL 40.0% vs. 28.2% requirement, Fitch BBB investment grade 2026-07-29 half-year; 2025-07-31 half-year.

Key risks (3 bullets)

1. Deal break risk — regulatory objection or High Court refusal would collapse c.1% of upside into a potential 20–30% drawdown toward pre-deal fundamentals; this is the dominant risk 2026-04-14 Rule 2.7 announcement; 2026-07-30 approval.
2. Interest-rate headwind to NIM post any deal break — NIM already compressed from 2.31% H1 2023 to 2.02% H1 2025 before recovering to 2.13% H1 2026; ECB rate decisions and deposit mix remain a sensitivity (c.€9m hit per 1% rate reduction based on static balance sheet) 2025-07-31 half-year.
3. Irish macro / tariff exposure — concentrated single-country exposure to Ireland, with explicit management flag on US trade tariff impact 2025-07-31 half-year and heightened geopolitical/climate overlays in impairment modelling 2026-07-29 half-year.

Operating leverage

Banks are fundamentally not operating-leverage stories in the sense this investor profile wants — the revenue line is driven by rates and loan volume with proportional capital and funding costs, and the "fixed" cost base (people, branches, tech) does leverage but modestly. PTSB's cost/income ratio has moved from 76% (H1 2025) to 71% (H1 2026) on a 7% revenue uplift and 1% cost reduction — demonstrating some leverage, but of order "revenue +7% → underlying PBT +34%", not multiples. Management's 2028 target of c.11% ROTE from current c.5% implies meaningful leverage from NIM widening (2.13% → >2.30%) plus cost/income to <60% 2025-10-30 Q3 trading statement. However, these are not the kinds of fixed-cost software economics the investor profile prizes, and in any case the deal removes PTSB shareholders from capturing this uplift.

Value-trap signals

• None identified in the traditional sense — balance sheet is strong, NPLs 1.4%, CET1 17.7%, dividends resumed.
• But: the stock trades at a small premium to the agreed offer, so any residual bull-case upside above 297c requires a bump that is not signalled and that BAWAG has not indicated.
• Return profile pre-deal (ROTE c.5% H1 2026 vs. 10%+ for AIB/BIRG) is structurally lower than Irish peers, which is partly why the Minister engaged in a sale rather than drip-sell on market.

Earnings vs. expectations

Across the period covered, PTSB has largely delivered in line with its own guidance: 2024 cost growth of mid-single-digit, 2024 NIM c.220bps and cost of risk –10bps all tracked guidance 2024-10-29 Q3. H1 2025 saw a decline in underlying PBT (–38%) that was pre-flagged as reflecting rate normalisation 2025-07-31 half-year. H1 2026 beat on revenue (+7%) with margin management ahead of plan. Pattern: largely in-line with occasional modest beats; no profit warnings or guidance cuts over the 5-year period. No external analyst-consensus benchmarks are explicitly cited in the filings, so this is management-guidance vs. actual.

Conviction

4 — high.

Anchors: (1) the fair-value call is tethered to a legally-binding, shareholder-approved cash offer at 297c with 91% approval and Minister support, so the methodology is unambiguous; (2) remaining regulatory steps are procedural with no public obstacles flagged; (3) current price is almost exactly at the offer, so limited valuation debate.

Caveats: (1) 1% premium to offer price suggests the market is pricing some residual probability of a bump that I cannot defend from the filings; (2) if the deal somehow fails, the fundamental fair value would be materially lower and the range widens considerably.

Overall assessment for this investor profile

PTSB is a fundamentally poor fit for the stated strategy. There is no AI-receiver angle (traditional Irish retail bank, spends on digital but captures no AI value chain uplift), no meaningful operating leverage of the "revenue beat → multiples of profit" type, and the valuation is capped by an announced cash offer at a –1% implied return. Downside protection is good only insofar as the deal closes; if it breaks, the stock would fall materially. For a non-strategic reader, this is cash-equivalent arbitrage at best, not a portfolio position.